PRIA Logo™
ArkansasHB18012025 Regular SessionHouse

TO AUTHORIZE AN OUTSOURCING FACILITY OF LEGEND DRUGS AND CONTROLLED SUBSTANCES THAT COMPOUNDS A PRODUCT TO SELL THE COMPOUNDED PRODUCT TO CERTAIN ENTITIES.

Sponsored By: Breanne Davis (Republican), Kendra Moore (Republican)

Enacted

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

New sales rules for compounded drugs

The law allows outsourcing facilities that compound prescription drugs and controlled substances to sell products through specified Arkansas healthcare channels. Facilities must be FDA-registered under section 503B and hold an Arkansas State Board of Pharmacy permit. Buyers must be Arkansas-licensed retail pharmacies dispensing to patients, healthcare facilities treating patients, or healthcare providers administering products in medical clinics. Sales to wholesalers, pharmaceutical repackagers or relabelers, marketing firms, and other entities are barred, except for those allowed buyers. Facilities must follow federal manufacturing standards in 21 C.F.R. Parts 210, 211, and 212 as they existed on January 1, 2025. The pharmacy board must adopt rules requiring retail pharmacies to educate patients about these compounds and identify the facility that prepared them. The board may require additional items it considers necessary.

Sponsors & Cosponsors

Sponsors

  • Breanne Davis

    Republican • Senate

  • Kendra Moore

    Republican • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 224 • No: 0

House vote • 4/16/2025

House Vote - Wednesday, April 16, 2025 1:40:31 PM

Yes: 91 • No: 0 • Other: 1

Senate vote • 4/10/2025

Senate Vote - Thursday, April 10, 2025 3:55:10 PM

Yes: 35 • No: 0

House vote • 3/31/2025

House Vote - Monday, March 31, 2025 3:20:38 PM

Yes: 98 • No: 0

Actions Timeline

  1. Notification that HB1801 is now Act 961

    4/21/2025House

  2. Correctly enrolled and ordered transmitted to the Governor's Office.

    4/16/2025House

  3. TO BE ENROLLED

    4/16/2025House

  4. Senate amendment # 1 read and concurred in.

    4/16/2025House

  5. Returned by the Committee with the recommendation that it do pass, concur in Senate Amendment No. 1

    4/15/2025House

  6. Re-referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE

    4/10/2025House

  7. Returned from Senate as passed, as amended # 1

    4/10/2025House

  8. Returned to the House as passed as amended # 1 .

    4/10/2025Senate

  9. Read the third time and passed.

    4/10/2025Senate

  10. REPORTED CORRECTLY ENGROSSED

    4/9/2025Senate

  11. Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.

    4/9/2025Senate

  12. Placed on second reading for purpose of amendment.

    4/9/2025Senate

  13. Rules suspended.

    4/9/2025Senate

  14. Returned by the Committee with the recommendation that it Do Pass as amended, Amendment # 1

    4/9/2025Senate

  15. Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE

    3/31/2025Senate

  16. Received from the House.

    3/31/2025Senate

  17. Read the third time and passed and ordered transmitted to the Senate.

    3/31/2025House

  18. Returned by the Committee Do Pass

    3/20/2025House

  19. Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE

    3/17/2025House

  20. Filed

    3/17/2025House

Bill Text

  • HB1801 - Introduced

    3/17/2025

    PDF

  • Act Version

    PDF

Related Bills

Back to State Legislation